Europe

EPO’s new examination guidelines: what you need to know

The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain.

Second medical use: a regulatory perspective 08-02-2021
The plausibility battleground at the EPO 09-11-2020
A stricter interpretation: the EPO and antibodies 27-10-2020
Why Santen ends Neurim-style SPCs 25-08-2020
How patents for transgenic mice got caught in a sufficiency trap 16-07-2020

More europe features

Latest europe news

Lundbeck loses €150m pay-for-delay appeal

30-03-2021

Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.